ÀÎÁ¦´ëÇб³ ÇØ¿î´ë ¹éº´¿ø Á¦12ȸ ´ëÇѽÅÀåÇÐȸ »ï³² ½ÉÆ÷Áö¾ö : 2019-04-06±³À°ÀÏÀÚ : 2019-04-06
±³À°Àå¼Ò : ÀÎÁ¦´ëÇб³ ÇØ¿î´ë ¹éº´¿ø 5Ãþ ´ë°´ç
±³À°ÁÖÁ¦ :
Á¦12ȸ ´ëÇѽÅÀåÇÐȸ »ï³² ½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ºÎ»ê.¿ï»ê.°æ³² Áöȸ
´ã´çÀÚ : ¼Û¿¬Á¤
¿¬¶ôó : 02-000-0000
À̸ÞÀÏ :
serigraph@naver.com ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
ºÎ»ê±¤¿ª½Ã±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í -µî·Ï : ´ëÇѽÅÀåÇÐȸ ȸ¿ø¿¡ ÇÑÇÔ
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 06ÀÏ ´ë°´ç 10:30~11:00 The Effect of dialysis modality on CKD progression in AKI Ȳ¿ø¹Î(°Ç¾ç´ë, ½ÅÀå³»°ú)
±³À°½Ã°£ 04¿ù 06ÀÏ ´ë°´ç 11:00~11:30 Fluid choice & Balance in Patients with Acute Kidney Injury ±èÈ¿Áø(µ¿±¹´ë, ½ÅÀå³»°ú)
±³À°½Ã°£ 04¿ù 06ÀÏ ´ë°´ç 12:30~13:00 Gut microbiome and the gut-kidney axis in CKD À̼ö¹Ì(µ¿¾Æ´ë, ½ÅÀå³»°ú)
±³À°½Ã°£ 04¿ù 06ÀÏ ´ë°´ç 13:00~13:30 Precision medicine in CKD : Identification of novel biomarkers and therapeutic targets ¼±ÀοÀ(ÀüÁÖ¿¹¼öº´¿ø, ½ÅÀå³»°ú)
±³À°½Ã°£ 04¿ù 06ÀÏ ´ë°´ç 13:30~14:00 Understanding of the complement-mediated glomerulonephritis È«À¯¾Æ(´ëÀü¼º¸ðº´¿ø, ½ÅÀå³»°ú)
±³À°½Ã°£ 04¿ù 06ÀÏ ´ë°´ç 14:00~14:30 The optimal approach to the treatment of IgA nephropathy in 2019 ÀÌÀ¯Áø(ÀÎÁ¦´ë, ½ÅÀå³»°ú)
±³À°½Ã°£ 04¿ù 06ÀÏ ´ë°´ç 14:50~15:20 Ischemic myocardial and brain injury during hemodialysis Á¤Á¾È¯(¿ø±¤´ë, ½ÅÀå³»°ú)
±³À°½Ã°£ 04¿ù 06ÀÏ ´ë°´ç 15:20~15:50 Precision Medicine in kidney transplantation : identification of novel biomarkers andtherapeutic targets ¹Ú¿ì¿µ(°è¸í´ë, ½ÅÀå³»°ú)